Effects of Fresh Royal Jelly on the Proliferation of Human Hepatoma Cell Line SMMC-7721
Proceedings of Anticancer Research · 1970
DOI: 10.26689/par.v1i2.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of Anticancer Research, 1970. Verfasst von Mingmin Wang. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Objective: To investigate the effect of fresh royal jelly on the proliferation of human hepatoma cell line SMMC-7721. Methods: We found that the administration of fresh royal jelly could alleviate the condition of hepatocellular carcinoma patients in a certain extent. The human hepatocellular carcinoma cell line SMMC-7721 was cultured in vitro. MTT colorimetric method was used to treat fresh cells and serum containing human serum. The effect of SMMC-7721 proliferation was observed. Results: The aqueous solution of fresh royal jelly had a certain effect on the proliferation of hepatoma cell line SMMC-7721 in a dose-dependent manner. The serum containing fresh royal jelly could inhibit the proliferation of human hepatoma cell line SMMC-7721, and its inhibitory effect showed dose-dependent. Conclusion: The serum containing fresh royal jelly has a significant inhibitory effect on the proliferation of human hepatoma cell line SMMC-7721 and its anti-cancer effect may be derived from its metabolites or stimulating the formation of immune-reactive substances in the body, in which in the clinical treatment of liver cancer and research have a certain value.
Zitieren
APA
Wang, M. (1970). Effects of Fresh Royal Jelly on the Proliferation of Human Hepatoma Cell Line SMMC-7721. Proceedings of Anticancer Research. https://doi.org/10.26689/par.v1i2.11
Vancouver
Wang M. Effects of Fresh Royal Jelly on the Proliferation of Human Hepatoma Cell Line SMMC-7721. Proceedings of Anticancer Research. 1970. doi:10.26689/par.v1i2.11
BibTeX
@article{Wang1970,
author = {Wang, Mingmin},
title = {Effects of Fresh Royal Jelly on the Proliferation of Human Hepatoma Cell Line SMMC-7721},
journal = {Proceedings of Anticancer Research},
year = {1970},
doi = {10.26689/par.v1i2.11}
}
EUVIMED